Research News and Research

RSS

Transparent develops new medium for Cell-able array kit to maintain metabolite activity

Transparent Inc. announced that it has developed a more advanced medium for Cell-able, a human hepatocyte array kit that has the potential to reduce drug development costs and time-to-market for pharmaceutical companies. Transparent first introduced Cell-able in the United States a year ago.

22 Nov 2010

Pope says condoms are justified in some cases to prevent HIV infection

Pope Benedict XVI says in a new book that condoms can be justified for male prostitutes seeking to stop the spread of HIV, a stunning comment for a church criticized for its opposition to condoms and for a pontiff who has blamed them for making the AIDS crisis worse, the Associated Press/Washington Post reports.

22 Nov 2010

New simple diagnostic tool to detect dangerous viruses

Boston University researchers have developed a simple diagnostic tool that can quickly identify dangerous viruses like Ebola and Marburg. The biosensor, which is the size of a quarter and can detect viruses in a blood sample, could be used in developing nations, airports and other places where natural or man-made outbreaks could erupt.

22 Nov 2010

HHS details health law MLR requirement: insurers must spend at least 80 percent on medical care

The medical loss ratio, also know as MLR, rule requires insurance companies to spend at least 80 cents of the premium dollar on medical care and quality. For employer plans covering more than 50 people, the requirement is 85 cents, according to The Associated Press.

22 Nov 2010

UC San Diego designated as Blue Distinction Center

UC San Diego Health System has been designated as a Blue Distinction Center for Spine Surgery and a Blue Distinction Center for Knee and Hip Replacement. This honor is awarded to medical facilities that have demonstrated expertise in delivering quality health care in certain specialty medical areas by the Blue Cross and Blue Shield Association.

22 Nov 2010

State roundup: Calif. stem cell research; Mass. prisons change HIV medicine procedure; Native Americans' high suicide rates

When millionaire Silicon Valley real estate developer Bob Klein launched his ballot drive to create a $3-billion state fund for stem-cell research in 2004, he pitched it as a way of taking politics out of science and focusing on cures.

22 Nov 2010

Asbestos awareness important to prevent related cancer: Experts

Experts from Perth speculate Western Australia is yet to see the peak of asbestos-induced cancer, with renovators still failing to take proper precautions. According to director of the National Centre for Asbestos Related Diseases, Bruce Robinson, the next and third wave of mesothelioma patients would come out of those putting themselves and others at risk while taking on DIY home renovation projects.

22 Nov 2010

Today's Op-Eds: The Ryan roadmap; Democrats and the doc fix; Health reform's failed promises; 'Don't litigate, innovate'

According to tax records unearthed by Bloomberg News, the health insurance lobby secretly gave $86.2 million to the U.S. Chamber of Commerce in 2009 to try to prevent the health care bill from becoming law. The huge contribution — 40 percent of the chamber's spending for that year — allowed the group to run ads against the bill without tainting the insurance industry, which was negotiating with Democrats on the bill at the same time (11/22).

22 Nov 2010

Big hospital clout dictates premiums

In a story for KQED, done in partnership with Kaiser Health News, Sarah Varney reports: "Over the last decade and a half, Sutter has gradually accumulated hospitals and amassed a roster of doctors who contract exclusively with the company.

22 Nov 2010

Employers scrutinize dependents for health coverage

The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).

22 Nov 2010

States mull Medicaid cuts, dropout possibilities

"Huge budget shortfalls are prompting a handful of states to begin discussing a once-unthinkable scenario: dropping out of the Medicaid insurance program for the poor," The Wall Street Journal reports. Officials in several states, including Washington, Texas, and South Carolina, have publicly pitched the idea.

22 Nov 2010

Research roundup: Health IT and malpractice; Wide variation in hospital rates; Income and insurance offerings

New England Journal of Medicine: Medical Malpractice Liability In The Age Of Electronic Health Records - "Providers can expect a varied and shifting landscape of medical liability risks and benefits as the adoption of [electronic health records] EHRs unfolds," write the authors who explore the ways EHRs may bring about long-term changes in standard of care and affect the course of malpractice litigation.

22 Nov 2010

Political cartoon: 'Waivers'

Kaiser Health News provides a fresh look at health policy developments with 'Waivers' by Lisa Benson.

22 Nov 2010

KHN column: The Roadmap lives

In his latest Kaiser Health News column, James Capretta writes: "Last year, Rep. Paul Ryan's 'Roadmap' -- his far-reaching plan to restore long-term budget balance through tax and entitlement reform -- was the subject of relentless attacks by those favoring a larger government role in American life. New York Times columnist Paul Krugman called Ryan the 'Flimflam Man' in a widely cited opinion piece in which he tried to dismiss the Roadmap as not a credible solution to the nation's budget problems.

22 Nov 2010

Helpson receives 'National High-Tech Enterprise' status

China Pharma Holdings, Inc., which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that its wholly owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd ("Helpson"), received the "National High-Tech Enterprise" status ("National HT Status") from the PRC government, as recognized by the Ministry of Science and Technology of China, the Ministry of Finance, and the State Administration of Taxation.

22 Nov 2010

Profil Institute expands capabilities to detect cardiac safety signals in diabetes and obesity clinical trials

Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the expansion of its capabilities for cardiac safety and cardiovascular efficacy studies in the company's early phase diabetes and obesity clinical trials.

22 Nov 2010

Grifols launches Flebogamma 10% DIF intravenous immune globulin in the U.S.

Grifols today announced availability of its recently approved Flebogamma® 10% DIF intravenous immune globulin. Grifols is a global healthcare company specializing in bioscience medicines derived from human plasma. Approval from the US Food and Drug Administration (FDA) for Flebogamma® 10% DIF was obtained in July 2010 and final approval in Europe is expected before the end of the year. Today's announcement signals widespread product availability to the US market.

22 Nov 2010

Cyberonics second quarter net sales increase 17% to $47.5 million

Cyberonics, Inc. today announced results for the quarter ended October 29, 2010.

22 Nov 2010

Medisafe 1 Technologies to develop new medical locking devices for intravenous administration

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that that the company's board of directors has approved the research and development of two new medical locking device products.

22 Nov 2010

$S*BIO begins SB1317 Phase 1 clinical trial in patients with advanced/refractory hematologic malignancies$

S*BIO begins SB1317 Phase 1 clinical trial in patients with advanced/refractory hematologic malignancies

S*BIO Pte Ltd today announced that a fourth novel, potential best-in-class compound discovered and developed by S*BIO has entered a Phase 1 clinical trial. The initiation of the study for S*BIO's oral multi-kinase inhibitor, SB1317 or TG02, in patients with advanced/refractory hematologic malignancies has triggered a payment from S*BIO's development and commercialization partner for the program, Tragara Pharmaceuticals.

22 Nov 2010

Research News and Research

Transparent develops new medium for Cell-able array kit to maintain metabolite activity

Pope says condoms are justified in some cases to prevent HIV infection

New simple diagnostic tool to detect dangerous viruses

HHS details health law MLR requirement: insurers must spend at least 80 percent on medical care

UC San Diego designated as Blue Distinction Center

State roundup: Calif. stem cell research; Mass. prisons change HIV medicine procedure; Native Americans' high suicide rates

Asbestos awareness important to prevent related cancer: Experts

Today's Op-Eds: The Ryan roadmap; Democrats and the doc fix; Health reform's failed promises; 'Don't litigate, innovate'

Big hospital clout dictates premiums

Employers scrutinize dependents for health coverage

States mull Medicaid cuts, dropout possibilities

Research roundup: Health IT and malpractice; Wide variation in hospital rates; Income and insurance offerings

Political cartoon: 'Waivers'

KHN column: The Roadmap lives

Helpson receives 'National High-Tech Enterprise' status

Profil Institute expands capabilities to detect cardiac safety signals in diabetes and obesity clinical trials

Grifols launches Flebogamma 10% DIF intravenous immune globulin in the U.S.

Cyberonics second quarter net sales increase 17% to $47.5 million

Medisafe 1 Technologies to develop new medical locking devices for intravenous administration

S*BIO begins SB1317 Phase 1 clinical trial in patients with advanced/refractory hematologic malignancies

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News